Unknown

Dataset Information

0

Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products.


ABSTRACT: Leukotrienes (LT) are lipid mediators of the inflammatory response that are linked to asthma and atherosclerosis. LT biosynthesis is initiated by 5-lipoxygenase (5-LOX) with the assistance of the substrate-binding 5-LOX-activating protein at the nuclear membrane. Here, we contrast the structural and functional consequences of the binding of two natural product inhibitors of 5-LOX. The redox-type inhibitor nordihydroguaiaretic acid (NDGA) is lodged in the 5-LOX active site, now fully exposed by disordering of the helix that caps it in the apo-enzyme. In contrast, the allosteric inhibitor 3-acetyl-11-keto-beta-boswellic acid (AKBA) from frankincense wedges between the membrane-binding and catalytic domains of 5-LOX, some 30?Å from the catalytic iron. While enzyme inhibition by NDGA is robust, AKBA promotes a shift in the regiospecificity, evident in human embryonic kidney 293 cells and in primary immune cells expressing 5-LOX. Our results suggest a new approach to isoform-specific 5-LOX inhibitor development through exploitation of an allosteric site in 5-LOX.

SUBMITTER: Gilbert NC 

PROVIDER: S-EPMC7747934 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products.

Gilbert Nathaniel C NC   Gerstmeier Jana J   Schexnaydre Erin E EE   Börner Friedemann F   Garscha Ulrike U   Neau David B DB   Werz Oliver O   Newcomer Marcia E ME  

Nature chemical biology 20200511 7


Leukotrienes (LT) are lipid mediators of the inflammatory response that are linked to asthma and atherosclerosis. LT biosynthesis is initiated by 5-lipoxygenase (5-LOX) with the assistance of the substrate-binding 5-LOX-activating protein at the nuclear membrane. Here, we contrast the structural and functional consequences of the binding of two natural product inhibitors of 5-LOX. The redox-type inhibitor nordihydroguaiaretic acid (NDGA) is lodged in the 5-LOX active site, now fully exposed by d  ...[more]

Similar Datasets

| S-EPMC7515697 | biostudies-literature
| S-EPMC8769927 | biostudies-literature
| S-EPMC8450076 | biostudies-literature
| S-EPMC5392699 | biostudies-literature
| S-EPMC4815237 | biostudies-literature
| S-EPMC4663473 | biostudies-literature
| S-EPMC7104245 | biostudies-literature
| S-EPMC2829362 | biostudies-literature
| S-EPMC10590419 | biostudies-literature
| S-EPMC9307165 | biostudies-literature